|
|
|
|
|||||||||||||
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thierry Ferreira, a postdoctoral fellow from France, works with Carolyn Slayman, Ph.D., on a problem that cuts across many diseases and all physiological systems: how proteins are transported to the cell surface. Cell trafficking, as this field of inquiry is called, is one of Yale’s great strengths, and the number of investigators approaching the inquiry from various angles creates a dynamic research environment. Yale is also known for the pace at which basic scientific discoveries are translated into new tools for understanding physiology and into new treatments themselves. Cell trafficking, for example, is the key to disorders ranging from cystic fibrosis to kidney disease. Diagnostic tests for a myriad of diseases depend on protein transport, as will progress in gene therapy. “To move a project forward,” says Slayman, who is Sterling Professor of Genetics and of Physiology and deputy dean for academic and scientific affairs, “you need to focus many different kinds of knowledge on the questions you’re asking. You need to reach out to colleagues and bridge the gap that exists all too often between scientific laboratories and clinical care. This can be tough when medicine has become so specialized, but we work hard to reduce that gap to a minimum.” The opportunity to work in a cohesive community of talented, visionary scientists attracts young researchers like Ferreira and distinguished senior faculty like Slayman from all over the world. |
|
 |
|
|
Last modified: Wednesday, 11-Aug-2004 14:59:40 EDT. (PL) |